MENU
BIAF
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
bioAffinity Technologies (BIAF) Ownership - Who owns bioAffinity Technologies?
bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment... Show more
Profile
Industry
N/A
Address
22211 W Interstate 10
Phone
+1 210 698-5334
Employees
14
Web
https://www.bioaffinitytech.com
Details
Group
Domestic Stock Funds
Category
Medical Specialties
Capitalization
23.27M
P/E Ratio
N/A
Total Cash
4.51M
Projected Growth
N/A
Total Debt
1.69M
Revenue
321.49K
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
0.41
Total Debt/Equity
N/A
Revenue/Share
0.04 USD as % of share price
Fundamentals
BIAF
Capitalization
23.3M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
4.51M
Total Cash/Share
0.41
Total Debt
1.69M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.04%
Revenue
321K
ROE
N/A
Book Value
6.99M
P/B Ratio
3.33
Cash Flow
N/A
Earnings
-0.43
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
64.5K
Current Ratio
3.07
Current Revenue Per Employee
21320.28
Dividends Per Share - Security
N/A
EBITDA
-7.01M
Float
N/A
Float - Current
N/A
Gross Income Margin
74.97
Revenue To Assets
-59.69
Shares Held By Institutions
346K
Shares Outstanding - Current
11.1M
Total Liabilities
3.2M
Total Volume MTD
N/A
Value
N/A
Gain YTD
19.780
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry MedicalSpecialties
Profile
Fundamentals
Details
Industry
N/A
Address
22211 W Interstate 10
Phone
+1 210 698-5334
Employees
14
Web
https://www.bioaffinitytech.com